Ekaterina Podyacheva is junior researcher of the Research Laboratory of Bioprosthetics and Cardiac Protection of the Institute of Experimental Medicine of Almazov, National Medical Research Centre, Ministry of Health of the Russian Federation. In 2020, she received a master's degree from St. Petersburg State University in biology. She investigates the pharmacokinetics, safety and specific activity of intravenous nicotinamide riboside in doxorubicin cardiomyopathy. Ekaterina Podyacheva studies the effects of doxorubicin on intercalated disc proteins and the effect of nicotinamide riboside on NAD+ metabolism. In addition, she looks for therapeutic agents in the development of doxorubicin-induced cardiotoxicity. Research interests: cardiovascular system, systemic circulation, vascular tone, polymorphisms, cardiomyopathy, doxorubicin, nicotinamide riboside, oxidative stress, adaptation.
Ekaterina Podyacheva is junior researcher of the Research Laboratory of Bioprosthetics and Cardiac Protection of the Institute of Experimental Medicine of Almazov, National Medical Research Centre, Ministry of Health of the Russian Federation. In 2020, she received a master's degree from St. Petersburg State University in biology. She investigates the pharmacokinetics, safety and specific activity of intravenous nicotinamide riboside in doxorubicin cardiomyopathy. Ekaterina Podyacheva studies the effects of doxorubicin on intercalated disc proteins and the effect of nicotinamide riboside on NAD+ metabolism. In addition, she looks for therapeutic agents in the development of doxorubicin-induced cardiotoxicity. Research interests: cardiovascular system, systemic circulation, vascular tone, polymorphisms, cardiomyopathy, doxorubicin, nicotinamide riboside, oxidative stress, adaptation.